Department of Medicine, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA; New Hampshire Colonoscopy Registry, Lebanon, New Hampshire, USA.
New Hampshire Colonoscopy Registry, Lebanon, New Hampshire, USA.
Gastrointest Endosc. 2020 Aug;92(2):387-393. doi: 10.1016/j.gie.2020.04.034. Epub 2020 Apr 26.
Because data on metachronous risk for patients with index proximal 5- to 9-mm hyperplastic polyps (HPs) are limited, the clinical significance of these polyps is unclear. Conversely, published data suggest that sessile serrated polyps (SSPs), traditional serrated adenomas (TSAs), and large (≥1 cm) HPs are high-risk lesions requiring close surveillance. We used data from the New Hampshire Colonoscopy Registry (NHCR) to examine the risk of metachronous large SPs and advanced neoplasias (ANs) in patients with 5- to 9-mm proximal HPs.
We included adults with at least 1 polyp resected at index colonoscopy and a surveillance examination 12 months or more after index. Outcomes were risk for metachronous large (≥1 cm) SPs and ANs (≥1 cm, villous elements, high-grade dysplasia, or colorectal cancer [CRC]). Individuals were hierarchically stratified by the most significant index SP. The risks for adults with proximal 5- to 9-mm HPs at index examination were compared with individuals with index findings of large (≥1 cm) HPs or any SSPs or TSAs, nonsignificant HPs (<1 cm in rectosigmoid or <5 mm anywhere in colon), high-risk adenomas (AAs or ≥3 adenomas, no SPs), and low-risk adenomas (no SPs). We present absolute and adjusted risks of metachronous polyps from a regression model that included age, sex, body mass index, smoking, previous polyp history, family history of CRC, year of diagnosis, endoscopist SP detection rates, and months to surveillance examination.
A total of 8560 NHCR participants were included (44.8% women; average age, 59.0 years; standard deviation, 9.1). Similar to those with large HPs or any SSPs/TSAs at index examination (odds ratio, 7.63; 95% confidence interval, 4.78-12.20), individuals with proximal 5- to 9-mm HPs had an elevated risk for metachronous large SPs (odds ratio, 4.77; 95% confidence interval, 2.54-8.94) as compared with adults with low-risk conventional adenomas.
NHCR data suggest that similar to adults with large HPs or any SSPs or TSAs at index examination, individuals with index 5- to 9-mm HPs proximal to the sigmoid are at an increased risk for metachronous large SPs. These novel data suggest that close surveillance intervals may be appropriate for patients with 5- to 9-mm proximal HPs.
由于目前关于近端 5-9 毫米增生性息肉(HP)患者的异时性风险数据有限,这些息肉的临床意义尚不清楚。相反,已发表的数据表明,无蒂锯齿状息肉(SSP)、传统锯齿状腺瘤(TSA)和大(≥1 厘米)HP 是需要密切监测的高危病变。我们利用新罕布什尔州结肠镜检查登记处(NHCR)的数据,检查了近端 5-9 毫米 HP 患者中异时性大(≥1 厘米)SP 和高级别肿瘤(ANs)的风险。
我们纳入了至少在索引结肠镜检查中切除了 1 个息肉且在索引后 12 个月或更长时间进行了监测检查的成年人。结果是异时性大(≥1 厘米)SP 和 ANs(≥1 厘米,绒毛成分,高级别异型增生或结直肠癌[CRC])的风险。个体按索引 SP 最显著的程度进行分层。将指数检查中近端 5-9 毫米 HP 患者的风险与具有大(≥1 厘米)HP 或任何 SSP 或 TSA、无意义的 HP(直肠乙状结肠<1 厘米或结肠任何部位<5 毫米)、高危腺瘤(AA 或≥3 个腺瘤,无 SP)和低危腺瘤(无 SP)的患者进行比较。我们从包括年龄、性别、体重指数、吸烟、既往息肉史、CRC 家族史、诊断年份、内镜医师 SP 检出率和监测检查时间在内的回归模型中呈现了异时性息肉的绝对和调整风险。
共纳入 8560 名 NHCR 参与者(44.8%为女性;平均年龄 59.0 岁;标准差 9.1)。与在索引检查中具有大 HP 或任何 SSP/TSA 的患者(比值比,7.63;95%置信区间,4.78-12.20)类似,近端 5-9 毫米 HP 患者发生异时性大 SSP 的风险升高(比值比,4.77;95%置信区间,2.54-8.94),与具有低危传统腺瘤的成年人相比。
NHCR 数据表明,与在索引检查中具有大 HP 或任何 SSP 或 TSA 的成年人类似,索引处近端 5-9 毫米 HP 的患者发生异时性大 SSP 的风险增加。这些新数据表明,对于近端 5-9 毫米的 HP 患者,密切监测间隔可能是合适的。